News
New guidelines issued for arthritis drugs
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7307.251/a (Published 04 August 2001) Cite this as: BMJ 2001;323:251- Helen Barratt
- BMJ
Patients with osteoarthritis or rheumatoid arthritis who are at high risk of gastrointestinal complications should have access to COX 2 (cyclo-oxygenase-2) selective inhibitors, according to new guidelines from the National Institute for Clinical Excellence.
The institute's long awaited report, which applies to patients in England and Wales, classified high risk patients as those …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.